Re-Evaluation of the Diagnostic Cut-Off for the Overnight Metyrapone Test Using Liquid Chromatography–Tandem Mass Spectrometry Measurement of 11-Deoxycortisol
Hormone and Metabolic Research · 23.10.2026
DOI: 10.1055/a-2976-3465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 23.10.2026. Verfasst von Jann A Hommen und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Düsseldorf Centre for Health and Society, Division for Specific Endocrinology, Germany, Düsseldorf. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
The overnight metyrapone test is an established tool for assessing the hypothalamic–pituitary–adrenal axis. The current diagnostic cut-off for serum 11-deoxycortisol (70 µg/L) is based on older immunoassays. With the introduction of liquid chromatography–tandem mass spectrometry, concerns have arisen regarding the validity of these thresholds. This study re-evaluates 11-deoxycortisol measured by liquid chromatography–tandem mass spectrometry in the overnight metyrapone test and assesses whether current cut-offs remain appropriate. In this retrospective diagnostic study, patients undergoing single-dose metyrapone testing after pituitary surgery (2017–2025) were included. Serum 11-deoxycortisol was measured using liquid chromatography–tandem mass spectrometry. A sufficient adrenal function was classified based on the absence of glucocorticoid therapy, lack of symptoms, normotension and normal laboratory findings. Receiver operating characteristic analysis was used to determine optimal thresholds. Diagnostic performance was evaluated using sensitivity, specificity, likelihood ratios, Matthews correlation coefficient, and bootstrap validation. Receiver operating characteristic analysis showed strong discrimination for detecting secondary adrenal insufficiency (area under the curve=0.953). Multiple statistical approaches consistently identified optimal cut-offs below 70 µg/L, in line with recent studies. Thresholds around 63–64 µg/L improved the balance between sensitivity and specificity. In contrast, the historical cut-off of 70 µg/L showed high sensitivity but reduced specificity, increasing the risk of false-positive results and unnecessary glucocorticoid substitution. The currently recommended cut-off for the OMT may be too high when using liquid chromatography–tandem mass spectrometry. Lower thresholds around 63–64 µg/L may improve diagnostic accuracy. Re-evaluation of current recommendations appears warranted.
Autor:innen und Institutionen
- University Hospital Düsseldorf Centre for Health and Society, Division for Specific Endocrinology, Germany, Düsseldorf.
Zitieren
APA
Hommen, J. A., Eberwein, T., Vogkou, C., Albeiruty, S., Muchalla, M., & Schott, M. (2026). Re-Evaluation of the Diagnostic Cut-Off for the Overnight Metyrapone Test Using Liquid Chromatography–Tandem Mass Spectrometry Measurement of 11-Deoxycortisol. Hormone and Metabolic Research. https://doi.org/10.1055/a-2976-3465
Vancouver
Hommen JA, Eberwein T, Vogkou C, Albeiruty S, Muchalla M, Schott M. Re-Evaluation of the Diagnostic Cut-Off for the Overnight Metyrapone Test Using Liquid Chromatography–Tandem Mass Spectrometry Measurement of 11-Deoxycortisol. Hormone and Metabolic Research. 2026. doi:10.1055/a-2976-3465
BibTeX
@article{Hommen2026,
author = {Hommen, Jann A and Eberwein, Tanja and Vogkou, Christiana and Albeiruty, Samer and Muchalla, Mareike and Schott, Matthias},
title = {Re-Evaluation of the Diagnostic Cut-Off for the Overnight Metyrapone Test Using Liquid Chromatography–Tandem Mass Spectrometry Measurement of 11-Deoxycortisol},
journal = {Hormone and Metabolic Research},
year = {2026},
doi = {10.1055/a-2976-3465}
}
EUVIMED